“We are pleased to announce that we have received FDA approval to begin human clinical trials,” Elon Musk’s company said in a statement. It is emphasized that this is an important first step, “which will one day allow our technology to help many people”, according to RIA News.
It is also reported that information on recruiting participants for clinical trials will be announced in the near future.
In late 2022, Elon Musk reported that Neuralink was seeking government approval to test the neural brain-computer interface in humans. As the businessman noted, “the revolutionary brain implant” can not only solve problems such as insomnia and paralysis, but also give the user “superhuman vision”.
Related Posts
